Healthcare, Biotech & Pharma - Startups in the genetic industry

The report analyses the evolution of the Healthcare, Biotech and Pharma sector with a specific focus on startups operating in genetics. It outlines how advanced technologies — including gene editing, gene and cell therapies, mRNA platforms, NGS and AI-driven systems — are transforming precision medicine and enabling safer, faster and more effective treatments.

The document highlights a new funding balance: after the pandemic peak, capital flows have normalised, with increased preference for small molecules due to lower costs and more predictable timelines, while CGT and RNA therapies remain highly innovative areas. The role of global innovation hubs (Boston, Cambridge, Basel, Singapore) is also central, accelerating the growth of startups with strong academic foundations.

The report presents more than 20 companies leading the next wave of innovation, detailing their platforms, pipelines, technological models and growth strategies that are reshaping the future of gene therapy and personalised medicine.

Download the abstract of the report for free. if you are interested in the full version of the report write to: businessdevelopment@intesasanpaoloinnovationcenter.com.